|
Name |
2-Methylbutane-2,3-diol
|
Molecular Formula | C5H12O2 | |
IUPAC Name* |
2-methylbutane-2,3-diol
|
|
SMILES |
CC(C(C)(C)O)O
|
|
InChI |
InChI=1S/C5H12O2/c1-4(6)5(2,3)7/h4,6-7H,1-3H3
|
|
InChIKey |
IDEOPBXRUBNYBN-UHFFFAOYSA-N
|
|
Synonyms |
2-Methylbutane-2,3-diol; 5396-58-7; 2-Methyl-2,3-butanediol; 2,3-Butanediol, 2-methyl-; 2,3-Dihydroxy-2-methylbutane; 2-methyl-butane-2,3-diol; NSC4324; NSC 4324; EINECS 226-414-3; Trimethylathylenglykol; AI3-24428; 2-methylbutan-2,3-diol; 2-methyl-butan-2,3-diol; SCHEMBL270139; (+)2 methyl butane 2,3-diol; DTXSID50871126; NSC-4324; MFCD00154004; AKOS014316243; BS-17228; CS-0161391; D80869; EN300-119724
|
|
CAS | 5396-58-7 | |
PubChem CID | 95362 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 104.15 | ALogp: | -0.1 |
HBD: | 2 | HBA: | 2 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 40.5 | Aromatic Rings: | 0 |
Heavy Atoms: | 7 | QED Weighted: | 0.509 |
Caco-2 Permeability: | -4.481 | MDCK Permeability: | 0.00022776 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.013 |
Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.008 |
Blood-Brain-Barrier Penetration (BBB): | 0.919 | Plasma Protein Binding (PPB): | 11.01% |
Volume Distribution (VD): | 0.863 | Fu: | 82.40% |
CYP1A2-inhibitor: | 0.031 | CYP1A2-substrate: | 0.158 |
CYP2C19-inhibitor: | 0.017 | CYP2C19-substrate: | 0.836 |
CYP2C9-inhibitor: | 0.004 | CYP2C9-substrate: | 0.58 |
CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.383 |
CYP3A4-inhibitor: | 0.004 | CYP3A4-substrate: | 0.216 |
Clearance (CL): | 5.91 | Half-life (T1/2): | 0.667 |
hERG Blockers: | 0.024 | Human Hepatotoxicity (H-HT): | 0.036 |
Drug-inuced Liver Injury (DILI): | 0.086 | AMES Toxicity: | 0.015 |
Rat Oral Acute Toxicity: | 0.019 | Maximum Recommended Daily Dose: | 0.017 |
Skin Sensitization: | 0.079 | Carcinogencity: | 0.056 |
Eye Corrosion: | 0.197 | Eye Irritation: | 0.982 |
Respiratory Toxicity: | 0.012 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001051 | 0.355 | D08QGD | 0.261 | ||||
ENC000016 | 0.333 | D08HZC | 0.241 | ||||
ENC001011 | 0.333 | D07QKN | 0.237 | ||||
ENC000906 | 0.321 | D0M8RC | 0.213 | ||||
ENC000719 | 0.308 | D00ZOF | 0.208 | ||||
ENC000590 | 0.303 | D07SJT | 0.205 | ||||
ENC000057 | 0.300 | D02OAV | 0.200 | ||||
ENC001709 | 0.290 | D0K5CB | 0.200 | ||||
ENC002736 | 0.286 | D0SS4P | 0.200 | ||||
ENC000874 | 0.280 | D06YPU | 0.200 |